Home » Topics » BioWorld Science

BioWorld Science
RSS

I-Mab Biopharma begins first-in-human study of TJ-003234

Jan. 28, 2019

SRPK1 found as therapeutic target for treating acute myeloid leukemia

Jan. 28, 2019

New phase I trial investigates use of MK-5475 in moderate to severe PAH

Jan. 28, 2019

Novo Nordisk initiates phase I pharmacokinetic study of NNC0148-0287sema in type 2 diabetes

Jan. 28, 2019

VCN-01 shows promising activity in preclinical models and in phase I study of retinoblastoma

Jan. 28, 2019

Immunosuppressive peptide R9-SOCS1-KIR prevents ocular damage in models of autoimmune uveitis

Jan. 28, 2019

Recombination, mutation probabilities linked

Jan. 28, 2019

Myelin can regenerate in MS but mostly doesn't

Jan. 28, 2019

NIAID initiates phase I study of the VRC-HIVRGP096-00-VP HIV vaccine

Jan. 28, 2019

Mannin Research and McMaster University enter glaucoma drug collaboration

Jan. 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...